Spectrum Pharma's cancer drug meets main goal in trial

April 23 (Reuters) - Spectrum Pharmaceuticals said its experimental cancer drug was shown to be safe and effective in a mid-stage trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.